Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Aventis initiates Lovenox trial in patients with acute STEMI

June 4, 2002

Ajinomoto describes factor Xa-inhibitory benzodiazepines

June 4, 2002

Piperazine-containing factor Xa inhibitors patented by Cor Therapeutics (Millennium)

June 4, 2002

Quinolines and isoquinolines identified as factor Xa inhibitors

May 30, 2002

Novel factor VIIa inhibitors identified at Aventis

May 27, 2002

Thrombin inhibitors in development at 3-Dimensional

May 24, 2002

Trypsin-like serine protease inhibitors patented by BioCryst

May 22, 2002

Novel gpIbIX antagonists in the Merck pipeline

May 21, 2002

New factor Xa inhibitors patented by Sankyo

May 17, 2002

Oral heparin fails to prove superiority to Lovenox in prevention of DVT

May 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...